Quantcast

Latest Morphinans Stories

2014-04-30 12:30:02

Patent Protection for KP511 Extends KemPharm's Intellectual Property Estate for Leading Franchise of Abuse-Deterrent Opioid Medications CORALVILLE, Iowa, April 30, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application titled, "Benzoic...

2014-04-30 08:33:23

Data from Clinical Drug-liking Studies Also to be Presented at APS Today STAMFORD, Conn., April 30, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that it has filed a New Drug Application (NDA) with the U.S. Food & Drug Administration (FDA) seeking authorization to market a once-daily, single-entity hydrocodone bitartrate tablet (HYD). This investigational pain medication was formulated to incorporate abuse-deterrent properties designed to make the product more difficult to manipulate...

2014-04-30 08:32:53

GeneSight® Analgesic Test Now Includes 22 Opioids and Non-opioid Pain Medications MASON, Ohio, April 30, 2014 /PRNewswire/ -- Assurex Health, Inc. today announced a significant expansion of its GeneSight® Analgesic test. The expanded test gives clinicians a multi-gene pharmacogenomics tool to guide medication decisions for patients with acute or chronic pain using patients' own genetic profiles to help determine their potential response to 22 medications across four relevant...

2014-04-29 20:26:48

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: The World Market for Pain Management Drugs and Deviceshttp://www.reportbuyer.com/pharma_healthcare/healthcare/world_market_pain_management_drugs_devices.html This study encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and as a result, the range of therapeutic options available to...

2014-04-29 12:33:30

STAMFORD, Conn., April 29, 2014 /PRNewswire/ -- Purdue Pharma L.P. will present results from a number of research studies at the American Pain Society (APS) 33(rd) Annual Scientific Meeting, April 30-May 3, 2014, in Tampa, Fla. Following is a schedule of select poster presentations: Authors Date / Time Title...

2014-04-29 08:35:55

WAYNE, Pa., April 29, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its first quarter financial results will be released on Tuesday, May 13, 2014. Following the announcement, Egalet's management will host a live conference call and webcast at 8:30 a.m. Eastern Time to review the company's financial and operating results and provide a general business update. http://photos.prnewswire.com/prnvar/20140219/NY67493LOGO Interested parties may...

2014-04-25 23:01:55

Teenagers are discovering heroin in record amounts which has facilitated the need for treatment. As teens enter adulthood, drug rehab facilities such as Arizona's The River Source are anticipating no shortage of those seeking help. Mesa, Arizona (PRWEB) April 25, 2014 A disturbing trend is taking form throughout high schools in the United States, and that is a dramatic increase in how many teenagers are both experimenting with and regularly using heroin. It is believed that this surge...

2014-04-24 16:28:55

High-risk Medication Utilization, Abuse Reduced MEMPHIS, Tenn. and SAN DIEGO, April 24, 2014 /PRNewswire/ -- Clinical interventions performed in conjunction with laboratory quantitative drug testing and monitoring were shown to reduce utilization of high risk medications in injured workers on chronic opioid therapy, according to a clinical study released by the merged entity of Progressive Medical and PMSI, in partnership with Millennium Laboratories. The study showed a decrease in...

2014-04-24 08:33:04

SAN DIEGO, April 24, 2014 /PRNewswire/ -- We at Zogenix have reviewed the letter to Vermont Governor Peter Shumlin signed by the Center for Lawful Access and Abuse Deterrence (CLAAD), The American Academy of Pain Management and the National Fibromyalgia & Chronic Pain Association, which asks the Governor and health commissioner to participate in a "multi-lateral meeting to develop a more thorough approach" to stemming Vermont's prescription drug abuse epidemic. We agree with and...

2014-04-23 08:31:19

SAN DIEGO, April 23, 2014 /PRNewswire/ -- Zogenix will continue to work to ensure patients suffering from severe chronic pain have access to the FDA-approved medications they need in every state nationwide, including Massachusetts. We are once again disappointed that Governor Patrick would issue another immediate restriction without first accepting our offer to discuss the facts and work together to address the needs of patients while combating abuse and addiction. We fully support...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.